Document is current
Any future updates will be listed below
-
Authors
Della Corte, Carminia Maria
Barra, Giusi
Ciaramella, Vincenza
Di Liello, Raimondo
Vicidomini, Giovanni
Zappavigna, Silvia
Luce, Amalia
Abate, Marianna
Fiorelli, Alfonso
Caraglia, Michele
Santini, Mario
Martinelli, Erika
Troiani, Teresa
Ciardiello, Fortunato
Morgillo, Floriana
-
Funding
Funding for this research was provided by:
Associazione Italiana Per La Ricerca Sul Cancro (IG- 2013-ID:14800)
Associazione Italiana Per La Ricerca Sul Cancro (MFAG 2013-N.14392)
- License Information
-
More Information
Article History
Received: 15 March 2019
Accepted: 30 May 2019
First Online: 13 June 2019
Ethics approval and consent to participate
: All human samples and biopsies were collected after obtaining a written informed consensus from any patient and healthy donor, in accordance with the Declaration of Helsinki. The use of these samples for research purposes was approved by our local Ethical Committee of Università della Campania “Luigi Vanvitelli”.
: All human samples and biopsies were collected after obtaining a written informed consensus from any patient and healthy donor, in accordance with the Declaration of Helsinki. The consensus form included the use of these samples for research purposes and consent for publication and was approved by our local Ethical Committee of Università della Campania “Luigi Vanvitelli”.
: EM: Advisory boards: Amgen, Bayer, Merck, Roche, Sanofi, Servier.TT: Advisory boards: Amgen, Bayer, Merck, Roche, Sanofi, Servier, Novartis.FC: Advisory Boards: Roche, Amgen, Merck, Pfizer, Sanofi, Bayer, Servier, BMS, Cellgene, Lilly; Institutional Research Grants: Bayer, Roche, Merck, Amgen, AstraZeneca, Ipsen.FM: Advisory Boards: MSD, Lilly; Institutional Research Grants: AstraZeneca.All other authors have no competing interests to disclose.
